InvestorsHub Logo
Followers 135
Posts 21967
Boards Moderated 2
Alias Born 04/17/2006

Re: None

Wednesday, 05/06/2015 3:31:02 AM

Wednesday, May 06, 2015 3:31:02 AM

Post# of 51
* Granted orphan drug status for ovarian cancer by FDA in June 2014

* Completed final pre-clinical studies required by the FDA

* Signed LOI with MD Anderson for Phase 1 clinical development

* Filing IND and initiating Phase 1:

- Investigational New Drug Application filed with the FDA in April 2015
- Begin Phase 1 -> third quarter calendar 2015
- Completed -> end of 2016

http://www.slideshare.net/CriticalOutcome/more-than-just-a-potential-breakthrough-treatment-for-many-cancers

https://twitter.com/CriticalOutcome/with_replies

$COTQF ~ $COT.V

YOU SHOULD NOT MAKE ANY DECISION, FINANCIAL, INVESTMENTS, TRADING OR OTHERWISE, BASED ON ANY OF THE INFORMATION PRESENTED IN THIS MESSAGE WITHOUT UNDERTAKING INDEPENDENT DUE DILIGENCE AND CONSULTATION WITH A PROFESSIONAL BROKER OR FINANCIAL ADVISOR.